Bitget App
スマートな取引を実現
暗号資産を購入市場取引先物Bitget Earn広場もっと見る

RX stock price forecast

How will RX stock perform in 2026 and 2030?

This page primarily displays the projected price range for RX stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of RX, the development trends of BioSyent Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for RX. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines BioSyent Inc.'s financial performance and industry trends to provide short-term price predictions for RX stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year RX stock price forecast

Price target:
24.63 CAD
+68.70%
Based on 1-year price forecasts from 42 analysts, the highest estimate is 35.62 CAD, while the lowest estimate is 11.58 CAD.

Analyst rating for RX

Based on ratings from 24 analysts over the past three months, the overall consensus is Sell.

Strong buy
6
Buy
1
Hold
0
Sell
17
Strong sell
0

よくあるご質問

How has RX's EPS performed recently?

RX's EPS is projected to reach -- CAD next quarter. Explore more BioSyent Inc. financial data and stay up to date on the company's latest developments on the RX stock details page.

What is the revenue forecast for RX next quarter?

BioSyent Inc.'s revenue is projected to reach 10.30M CAD CAD in the next quarter. You can view BioSyent Inc.'s revenue and earnings on the RX stock details page.

What is the price target for RX?

Based on analyst estimates, the most likely target price for RX over the next 12 months is 24.63 CAD, with a projected high of 35.62 CAD and a projected low of 11.58 CAD. To track whether this target is reached within the next year, you can view the RX stock price chart on the RX stock details page to check the current RX stock price, or follow the latest developments related to RX on the RX Stock News page.

What is the analyst rating for RX?

We collected ratings from 24 analysts who have evaluated RX stock over the past three months. Most analysts maintain a Sell outlook, and after aggregating all opinions, the overall consensus rating is Sell. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of RX stock in 2030?

Based on price forecasts and analyses of BioSyent Inc. from Wall Street analysts and major investment banks, RX is projected to trade between 29.20 CAD and 146.00 CAD in 2030.

RX stock chart

RX stock details

RXの株価変動

最終取引日において、RX株式の終値は14.60 CADで、1日の価格変動は0.00%でした。

株式先物を取引

Bitgetについて

世界初のユニバーサル取引所(UEX)では、ユーザーは暗号資産だけでなく、株式、ETF、外国為替、金、現実資産(RWA)も取引できます。
詳細を見る
TSXV/
RX stock price forecast
© 2026 Bitget